Suppr超能文献

在已有巩膜扣带的眼中植入Baerveldt引流植入物。

Baerveldt drainage implants in eyes with a preexisting scleral buckle.

作者信息

Scott I U, Gedde S J, Budenz D L, Greenfield D S, Flynn H W, Feuer W J, Mello M O, Krishna R, Godfrey D G

机构信息

Department of Opthalmology, Bascom Palmer Eye Institute, University of Miami School of Medicine, PO Box 016880, Miami, FL 33101, USA.

出版信息

Arch Ophthalmol. 2000 Nov;118(11):1509-13. doi: 10.1001/archopht.118.11.1509.

Abstract

OBJECTIVE

To describe the surgical insertion of a Baerveldt drainage implant and postoperative visual acuity and intraocular pressure (IOP) outcomes in patients with a preexisting scleral buckle.

METHODS

Medical records of all patients with a preexisting scleral buckle who underwent insertion of a Baerveldt drainage implant at Bascom Palmer Eye Institute, Miami, Fla, from January 1, 1994, through December 31, 1998, were reviewed. Outcome measures included visual acuity and IOP at 1 year.

RESULTS

At 1 year postoperatively, 14 (88%) of 16 patients had stable or improved visual acuity. Preoperatively, mean IOP was 30.9 mm Hg and the mean number of antiglaucoma medications was 3.4; at 1 year postoperatively, mean IOP was 12.0 mm Hg and the mean number of antiglaucoma medications was 0.8 (P<.001). Nine patients (56%) achieved an IOP of greater than 5 and no greater than 21 mm Hg without medication, and an additional 7 (44%) achieved this level of IOP control with medication. No patient required further surgery for uncontrolled IOP during the follow-up interval, which ranged from 19. 1 to 45.5 months.

CONCLUSION

Baerveldt drainage device insertion behind or over a preexisting encircling band is often successful in managing refractory glaucoma in patients who have undergone previous scleral buckling procedures. Arch Ophthalmol. 2000;118:1509-1513

摘要

目的

描述在已有巩膜扣带术的患者中植入Baerveldt引流植入物的手术操作以及术后视力和眼压(IOP)的结果。

方法

回顾了1994年1月1日至1998年12月31日在佛罗里达州迈阿密市巴斯科姆·帕尔默眼科研究所接受Baerveldt引流植入物植入的所有已有巩膜扣带术的患者的病历。观察指标包括术后1年的视力和眼压。

结果

术后1年,16例患者中有14例(88%)视力稳定或提高。术前平均眼压为30.9 mmHg,平均抗青光眼药物使用数量为3.4种;术后1年,平均眼压为12.0 mmHg,平均抗青光眼药物使用数量为0.8种(P<0.001)。9例患者(56%)在未使用药物的情况下眼压达到大于5且不大于21 mmHg,另外7例(44%)通过药物治疗达到了该眼压控制水平。在随访期间(19.1至45.5个月),没有患者因眼压控制不佳而需要进一步手术。

结论

在已有环扎带后方或上方植入Baerveldt引流装置,对于既往接受过巩膜扣带手术的难治性青光眼患者,通常能成功控制眼压。《眼科学文献》。2000年;118:1509 - 1513

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验